CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 224 enrolled
Drug / intervention
lignocaine +1 moredrug
Likely dose
Midazolam 1 milligram Prefilled Syringefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04921046
NCT04921046Phase 4Completed
CompareCT.gov

Effect of Pretreatment of Lignocaine Versus Midazolam in the Prevention of Etomidate Induced Myoclonus

Rawalpindi Medical College·interventional·Posted Jun 10, 2021·Updated Jun 10, 2021

In Brief

A Phase 4 clinical trial evaluating lignocaine and Midazolam 1 milligram Prefilled Syringe for Myoclonic Jerk. Completed, enrolled 224 participants.

Detailed Summary

This study is a randomized control trial and it was conducted to compare the effectiveness of pretreatment with lignocaine versus midazolam on the frequency of myoclonus associated with etomidate induction. This was conducted in Holy Family Hospital Rawalpindi in a period of 6 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyoclonic Jerk
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 10, 2021
Enrollment StartJan 1, 2015
Primary CompletionJun 30, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.1 years ago

Interventions

lignocainedrug

After giving lignocaine to a group of people, myoclonus was observed after the dose of etomidate given two minutes after lignocaine.

Midazolam 1 milligram Prefilled Syringedrug

after giving midazolam to the second group of people two minutes before etomidate dose, myoclonus was observed for one minute.